Thomas G Wiggans insider trades

Open-market stock purchases and sales by Thomas G Wiggans, Director at Jasper Therapeutics, Inc, from SEC Form 4 filings since Dec 31, 2009.

Track record: 0% of 11 scored buys are up 5% or more since purchase, averaging -38%.

Recent trades

DateStockTradeValue
Jul 31, 2026JSPR Jasper Therapeutics, IncBought (not open market)—
Jun 10, 2026PCRX Pacira BioSciences, IncBought (not open market)—

Companies traded

  • JSPR Jasper Therapeutics, Inc: 6 buys, last Jul 31, 2026
  • PCRX Pacira BioSciences, Inc: other filings, last Jun 10, 2026
  • ANNX Annexon, Inc: other filings, last Jun 5, 2025
  • CBAY CymaBay Therapeutics, Inc: other filings, last Mar 22, 2024
  • PRDS Pardes Biosciences, Inc: 3 buys, last Aug 31, 2023
  • FMTX Forma Therapeutics Holdings, Inc: other filings, last Oct 14, 2022
  • DERM Dermira, Inc: 5 buys, 41 sales, last Feb 20, 2020
  • ONXX Onyx Pharmaceuticals Inc: 8 sales, last Oct 1, 2013
  • SOMX Somaxon Pharmaceuticals, Inc: 1 sale, last Jul 2, 2012
  • SGMO Sangamo Biosciences Inc: other filings, last Jun 1, 2011

Get free alerts when Thomas G Wiggans files a new trade →